Aránzazu Mediero - Concepedia

Author

Aránzazu Mediero

Hospital Universitario Fundación Jiménez Díaz ORCID

Also Known As

A Mediero, A. Mediero, Ara nzazu Mediero, Arancha Mediero, Aranzazu Mediero, Aranzazu Mediero‐Munoz, Ara´nzazu Mediero, Aránzazu Mediero, Aránzazu Mediero-Muñoz

117

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Fundación Jiménez Díaz Universidad Autónoma de Madrid New York University Universidad Complutense de Madrid Hospital Clínico San Carlos

About

Aránzazu Mediero is an author at Hospital Universitario Fundación Jiménez Díaz specializing in medicine, engineering, and biomedical engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	174
2	Engineering	3	3	84
3	Biomedical Engineering	3	3	84
4	Social Sciences	1	1	33
5	Anesthesia	1	1	33

Aránzazu Mediero

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Bone regeneration in critical bone defects using three‐dimensionally printed β‐tricalcium phosphate/hydroxyapatite scaffolds is enhanced by coating scaffolds with either dipyridamole or BMP‐2 Stephanie Ishack, Aránzazu Mediero, Tuere Wilder, Journal of Biomedical Materials Research Part B Applied Biomaterials	2015	134
Direct or indirect stimulation of adenosine A <sub>2A</sub> receptors enhances bone regeneration as well as bone morphogenetic protein‐2 Aránzazu Mediero, Tuere Wilder, Miguel Pérez‐Aso, The FASEB Journal	2015	98
Adenosine A2A Receptor Ligation Inhibits Osteoclast Formation Aránzazu Mediero, Firas M. Kara, Tuere Wilder, American Journal Of Pathology	2011	95
Activation of adenosine <scp>A<sub>2A</sub></scp> receptor reduces osteoclast formation via <scp>PKA</scp>‐ and <scp>ERK1</scp>/2‐mediated suppression of <scp>NF</scp>κ<scp>B</scp> nuclear translocation Aránzazu Mediero, Miguel Pérez‐Aso, Bruce N. Cronstein British Journal of Pharmacology	2013	90
Adenosine A<sub>2A</sub>Receptor Activation Prevents Wear Particle–Induced Osteolysis Aránzazu Mediero, Sally R. Frenkel, Tuere Wilder, Science Translational Medicine	2012	82
Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors Miguel Pérez‐Aso, M. Carmen Montesinos, Aránzazu Mediero, Arthritis Research & Therapy	2015	73
Adenosine 2A receptor promotes collagen production by human fibroblasts <i>via</i> pathways involving cyclic AMP and AKT but independent of Smad2/3 Miguel Pérez‐Aso, Patricia Fernández, Aránzazu Mediero, The FASEB Journal	2013	67
Netrin-1 Is a Critical Autocrine/Paracrine Factor for Osteoclast Differentiation Aránzazu Mediero, Bhama Ramkhelawon, Miguel Pérez‐Aso, Journal of Bone and Mineral Research	2014	63
Natriuretic peptide system in the human retina. Raquel Rollín, Aránzazu Mediero, Manuela Roldán Pallarés, PubMed	2004	63
Ticagrelor regulates osteoblast and osteoclast function and promotes bone formation in vivo <i>via</i> an adenosine‐dependent mechanism Aránzazu Mediero, Tuere Wilder, Vishnu S. R. Reddy, The FASEB Journal	2016	63

Page 1